Elevation Oncology Inc. (ELEV)
NASDAQ: ELEV
· Real-Time Price · USD
0.38
0.06 (18.79%)
At close: Jun 09, 2025, 3:59 PM
Elevation Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 58K | 58K | 58K | 58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 9K | 19K | 29K | 33K | 39K | 39K | 39K | 38K | 33K | 27K | 22K | 17K | 18K | 18K | 13K | 10K | 4K |
Gross Profit | -9K | -19K | 29K | 25K | 19K | 19K | -39K | -38K | -33K | -27K | -22K | -17K | -18K | -18K | -13K | -10K | -4K |
Operating Income | -49.05M | -44.7M | -42.01M | -39.7M | -38.57M | -45.45M | -56.04M | -83.65M | -93.93M | -94.55M | -85.64M | -59.38M | -44.33M | -32.05M | -31.31M | -22.04M | -20.4M |
Interest Income | n/a | n/a | 3.9M | 3.9M | 3.9M | 3.9M | 234.00 | 234.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -47.95M | -44.44M | -41.91M | -39.66M | -39.32M | -45.67M | -56.8M | -85.01M | -94.83M | -95.06M | -85.66M | -59.09M | -44.22M | -32.04M | -31.31M | -22.05M | -20.4M |
Net Income | -47.99M | -44.48M | -41.95M | -39.7M | -39.35M | -45.7M | -56.85M | -85.35M | -94.98M | -95.11M | -85.69M | -58.81M | -44.13M | -32.04M | -31.31M | -22.05M | -20.4M |
Selling & General & Admin | 16.21M | 16.09M | 15.34M | 15M | 14.4M | 14.89M | 15.68M | 16.38M | 16.39M | 15.83M | 15.17M | 13.96M | 11.29M | 8.45M | 5.53M | 3.01M | 2.28M |
Research & Development | 29.46M | 28.6M | 26.64M | 24.68M | 24.15M | 25.43M | 35.24M | 62.16M | 72.43M | 78.72M | 70.46M | 45.42M | 33.04M | 23.59M | 25.78M | 19.03M | 18.12M |
Other Expenses | 3.38M | n/a | 56K | 351K | 80K | -229K | -765K | -1.37M | -908K | -506K | -24K | 292K | 105K | 7K | 2K | -7K | 5K |
Operating Expenses | 49.05M | 44.69M | 41.98M | 39.67M | 38.55M | 40.33M | 50.93M | 78.54M | 88.82M | 94.55M | 85.64M | 59.38M | 44.33M | 32.05M | 31.31M | 22.04M | 20.4M |
Interest Expense | 1.09M | 1.2M | 4.8M | 4.8M | 4.28M | 4.48M | 779K | 1.08M | 1.08M | 776K | 306K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -3.84M | n/a | 3.83M | 3.83M | 3.83M | -10K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 34.83M | 44.7M | 42.01M | 39.7M | 38.57M | 40.34M | 50.93M | 78.54M | 88.82M | 94.55M | 85.64M | 59.38M | 44.33M | 32.05M | 31.31M | 22.04M | 20.4M |
Income Tax Expense | 38K | 43K | 43K | 42K | 36K | 30K | 46K | 341K | 149K | 51K | 26K | -280K | -93K | n/a | n/a | -3.01M | -6.43M |
Shares Outstanding (Basic) | 59.17M | 59.12M | 59.11M | 59.02M | 47.37M | 42.42M | 42.4M | 27.58M | 23.62M | 23.3M | 23.29M | 23.26M | 23.22M | 12.13M | 23.11M | 1.05M | 22.82M |
Shares Outstanding (Diluted) | 59.17M | 59.12M | 59.11M | 59.02M | 47.37M | 42.42M | 42.4M | 27.58M | 23.62M | 23.3M | 23.29M | 23.26M | 23.22M | 12.13M | 23.11M | 1.05M | 22.82M |
EPS (Basic) | -0.82 | -0.81 | -0.82 | -0.85 | -1.04 | -1.53 | -2.16 | -3.59 | -4.07 | -4.09 | -4.06 | -2.91 | -6.9 | -6.38 | -6.13 | -5.78 | -1.15 |
EPS (Diluted) | -0.82 | -0.81 | -0.82 | -0.85 | -1.04 | -1.53 | -2.16 | -3.59 | -4.07 | -4.09 | -4.06 | -2.91 | -6.9 | -6.38 | -6.13 | -5.78 | -1.15 |
EBITDA | -47.86M | -43.51M | -41.98M | -39.66M | -38.53M | -40.3M | -50.9M | -78.51M | -88.8M | -94.53M | -85.61M | -59.37M | -44.31M | -32.03M | -31.28M | -19.01M | -13.95M |
EBIT | -33.66M | -43.53M | -43.14M | -40.83M | -39.7M | -41.47M | -50.93M | -78.54M | -88.82M | -94.55M | -85.64M | -59.38M | -44.33M | -32.05M | -31.31M | -22.04M | -20.4M |
Depreciation & Amortization | 14K | 24K | 29K | 33K | 39K | 39K | 39K | 38K | 33K | 27K | 22K | 17K | 18K | 18K | 28K | 3.04M | 6.45M |